GET THE APP

..

Cancer Science & Therapy

ISSN: 1948-5956

Open Access

Lingxiao Zhang


Department of Medical Oncology, The First Affiliated Hospital of Xian Jiaotong University, Xi’an, P.R. China

Biography
Department of Medical Oncology, The First Affiliated Hospital of Xian Jiaotong University, Xi’an, P.R. China ,  EGFR;  Erlotinib;  Osimertinib;  Lung  adenocarcinoma;   Circulating tumor DNA assay, EGFR Primary T790M and L858R Double Mutation Confers Clinical  Benefit to Erlotinib and Resistance to Osimertinib in One Lung  Adenocarcinoma Patient: A Case Report

Relevant Topics

Google Scholar citation report
Citations: 3968

Cancer Science & Therapy received 3968 citations as per Google Scholar report

Cancer Science & Therapy peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward